<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03929289</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0268</org_study_id>
    <secondary_id>2019-A01027-50</secondary_id>
    <nct_id>NCT03929289</nct_id>
  </id_info>
  <brief_title>The Visuo-attentional Mediator of Social Facilitation</brief_title>
  <acronym>VAMOS</acronym>
  <official_title>The Visuo-attentional Mediator of Social Facilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Social psychology has long established that the mere presence of others influences the&#xD;
      investigator's individual behavior and performance. &quot;Social facilitation&quot; refers to any&#xD;
      improvement or deterioration of performance due to the presence of others. For more than a&#xD;
      century, social psychology has acquired a solid knowledge of the principles governing this&#xD;
      fundamental form of social influence.&#xD;
&#xD;
      But the underlying mechanism of social facilitation remains debated, as behavior alone cannot&#xD;
      identify it with certainty. This major unresolved problem makes it particularly difficult to&#xD;
      translate laboratory results on social facilitation into real applications in areas such as&#xD;
      school or work, where others are ubiquitous. The purpose of this study will therefore be to&#xD;
      identify the mediator of social facilitation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2021</start_date>
  <completion_date type="Anticipated">April 16, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 16, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activation</measure>
    <time_frame>50 minutes</time_frame>
    <description>Cerebral Blood Oxygenation Level-Dependent (BOLD) signals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>pupillary diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>error rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>reaction time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>oculomotor kinematic parameters: velocity of saccades.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>oculomotor kinematic parameters: duration of saccades.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>oculomotor kinematic parameters: precision of saccades.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Social Facilitation</condition>
  <arm_group>
    <arm_group_label>Social Facilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive tasks during the 2 functional Magnetic Resonance Imaging (fMRI) observed or not by a subject's known peer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Facilitation</intervention_name>
    <description>During the functional Magnetic Resonance Imaging (fMRI) scans, the subject will perform cognitive tasks measuring eye movements and attention alternatively observed by a familiar peer (in an adjacent room) or not.</description>
    <arm_group_label>Social Facilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  Aged 18 to 35 years old&#xD;
&#xD;
          -  Signed written informed consent&#xD;
&#xD;
          -  Insurance coverage&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neurological or psychiatric or ophthalmological disorder&#xD;
&#xD;
          -  Non-stabilized medical condition&#xD;
&#xD;
          -  Ongoing treatment with drugs that affect the central nervous system&#xD;
&#xD;
               -  Uncorrected visual inadequacy&#xD;
&#xD;
               -  No fluency in French reading&#xD;
&#xD;
               -  Pregnant and / or breastfeeding woman, this exclusion criterion will be sought by&#xD;
                  questioning the subject&#xD;
&#xD;
               -  Subject commonly in care in a health or social facility for purposes other than&#xD;
                  that of research&#xD;
&#xD;
               -  Subject under guardianship&#xD;
&#xD;
               -  Subject deprived of liberty by a judicial or administrative decision&#xD;
&#xD;
               -  Incompatibility with the Magnetic Resonance Imaging (MRI) examination determined&#xD;
                  by answering the following questions:&#xD;
&#xD;
          -  Carrier of a neurological stimulator, cardiac (battery) or defibrillator&#xD;
&#xD;
          -  Carrier of a cardiac prosthesis (valve, stent ...) or vascular&#xD;
&#xD;
          -  Holder of intracranial clips or clamps (staples)&#xD;
&#xD;
          -  Carrier of a cerebrospinal fluid bypass&#xD;
&#xD;
          -  Presence of metal chips in the eyes&#xD;
&#xD;
          -  Metal prosthesis carrier (teeth, knees)&#xD;
&#xD;
          -  Pump carrier or infusion system&#xD;
&#xD;
          -  Presence of metal tattoo near the head&#xD;
&#xD;
          -  Presence of permanent makeup&#xD;
&#xD;
          -  Claustrophobia or respiratory disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denis PELISSON</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche en Neuroscience de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denis PELISSON</last_name>
    <phone>4 72 91 34 17</phone>
    <phone_ext>+33</phone_ext>
    <email>denis.pelisson@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martine MEUNIER</last_name>
    <phone>4 72 91 34 17</phone>
    <phone_ext>+33</phone_ext>
    <email>martine.meunier@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherche en Neuroscience de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis PELISSON</last_name>
      <phone>4 72 91 34 17</phone>
      <phone_ext>+33</phone_ext>
      <email>denis.pelisson@inserm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Martine MEUNIER</last_name>
      <phone>4 72 91 34 17</phone>
      <phone_ext>+33</phone_ext>
      <email>martine.meunier@inserm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Denis PELISSON</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2019</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Functional Magnetic Resonance Imaging (fMRI)</keyword>
  <keyword>Healthy Subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

